A.B.Korkor Medical announces the FDA clearance of the AngioExpand catheter introducer (K092097). The original name of the product was the Skinnysafe, but upon guidance from the FDA, the name has been changed to better reflect the product.
May, 2016 – Radial Access Adoption in the United States
The use of transradial artery vascular access for percutaneous coronary intervention (PCI) in the United States has seen a rapid rise in the past few years. However, it still only accounts for around 27 percent of PCIs, …
Feb 8, 2011 – Wall St. Journal – Wrist May Be Route to Safer Heart Treatment
April 8, 2011 — The first large-scale trial comparing angioplasty performed via the wrist (transradial) with the procedure done from the leg (femoral) was presented at this week’s annual meeting of the American College of Cardiology. Dubbed “RIVAL” (RadIal Vs. FemorAL Access for Coronary Intervention Study) the trial enrolled 7,021 patients from 158 hospitals in 32 countries. These were patients with Acute Coronary Syndrome (ACS) who were experiencing unstable angina or a heart attack (either NSTEMI or STEMI) — and who were going to be treated with angioplasty and/or stents.
The question for the RIVAL study: Is radial access superior to femoral?